Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 1;48(11):18-25.
doi: 10.1097/01.NPR.0000000000000110.

An overview of myofascial pain syndrome with a focus on trigger point injection

Nicole Bodine  1
Affiliations
Review

An overview of myofascial pain syndrome with a focus on trigger point injection

Nicole Bodine. Nurse Pract. .

Abstract

Myofascial pain syndrome (MPS) is a very common condition, with an estimated lifetime prevalence of 85% in the general population. MPS is commonly underdiagnosed or misdiagnosed due to the lack of standardized diagnostic criteria and the symptoms' overlap with those of other musculoskeletal pain conditions. The most notable and bothersome feature of MPS is the presence of myofascial trigger points (MTrPs), hypersensitive areas of muscle commonly characterized as knots, nodules, or bumps that cause strain and pain with and oftentimes without stimulation. A low-risk, low-cost procedure, trigger point injection (TPI) is the gold standard for MPS treatment, and NPs can perform the procedure in an outpatient practice setting. Through administration of TPIs and use of other treatment modalities, primary care NPs can significantly impact the quality of life for those patients affected by acute and chronic MPS. This article aims to educate primary care NPs on MPS diagnosis and provide an overview of treatment options, with a focus on TPI use and administration for MPS relief.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Roldan CJ, Osuagwu U, Cardenas-Turanzas M, Huh BK. Normal saline trigger point injections vs conventional active drug mix for myofascial pain syndromes. Am J Emerg Med . 2020;38(2):311–316. doi:10.1016/j.ajem.2019.158410.
    1. Giamberardino MA, Affaitati G, Fabrizio A, Costantini R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol . 2011;25(2):185–198. doi:10.1016/j.berh.2011.01.002.
    1. Charles D, Hudgins T, MacNaughton J, Newman E, Tan J, Wigger M. A systematic review of manual therapy techniques, dry cupping and dry needling in the reduction of myofascial pain and myofascial trigger points. J Bodyw Mov Ther . 2019;23(3):539–546. doi:10.1016/j.jbmt.2019.04.001.
    1. Simons DG, Travell JG, Simons LS. Travell & Simons' Myofascial Pain and Dysfunction. The Trigger Point Manual . 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.
    1. Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Med Clin North Am . 2007;91(2):229–239. doi:10.1016/j.mcna.2006.12.004.